The Longitudinal Assessment of Prenatal Cannabis Use on Neonatal Outcomes DOI Creative Commons

Leah habersham,

Yasmin L. Hurd, Yoko Nomura

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: Feb. 5, 2024

Abstract Objective Investigate the association between prenatal cannabis use and neonatal outcomes using longitudinal data from pregnant individuals. Study Design Data was leveraged Stress in Pregnancy study, conducted 2009 2013. Interviews electronic medical records of 894 individuals were analyzed, with 791 identified as cannabis. Cannabis (NICU admission, preterm delivery, low birth weight, fetal death) investigated. Results Among participants 13.1% used cannabis, who generally younger (25.9 vs 27.9 years). Unadjusted analysis indicated a seven-fold increased risk death (OR 7.30) which persisted after adjustments (aOR 6.31). Adjusted models also suggested weight 1.67). Conclusion This study highlights an elevated risks for weight. Funding Support: NIH T32HL160513, NIDA R25DA033211, NIDA R01DA057310, Addiction Institute Mount Sinai internal funds

Language: Английский

Are Health Care Providers Caring for Pregnant and Postpartum Women Ready to Confront the Perinatal Cannabis Use Challenge? DOI
Panagiota Kitsantas,

Shannon R. Pursell

American Journal of Perinatology, Journal Year: 2023, Volume and Issue: 41(S 01), P. e3249 - e3254

Published: Dec. 13, 2023

The purpose of this study was to assess health care providers' knowledge and practices related cannabis use among pregnant postpartum women.

Language: Английский

Citations

3
Current Evidence to Guide Practice, Policy, and Research: Cannabis Use During Pregnancy DOI
Summer Sherburne Hawkins

JOGN Nursing, Journal Year: 2022, Volume and Issue: 51(6), P. 643 - 650

Published: Oct. 4, 2022

Language: Английский

Citations

4
Incidence of postpartum depression in low-income cannabis users with and without a history of depression DOI

Anastasia Lendel,

Ria Richards,

Jason B. Benedict

et al.

Archives of Women s Mental Health, Journal Year: 2023, Volume and Issue: 27(1), P. 145 - 151

Published: Nov. 1, 2023

Language: Английский

Citations

2
A Review of Associations between Externalizing Behaviors and Prenatal Cannabis Exposure: Limitations & Future Directions DOI Creative Commons
Ami S. Ikeda, Valerie S. Knopik, L. Cinnamon Bidwell

et al.

Toxics, Journal Year: 2022, Volume and Issue: 10(1), P. 17 - 17

Published: Jan. 5, 2022

In utero cannabis exposure can disrupt fetal development and increase risk for various behavioral disruptions, including hyperactivity, inattention, delinquent behaviors, later substance abuse, among others. This review summarizes the findings from contemporary investigations linking prenatal to of psychopathology identifies limitations within literature, which constrain our interpretations generalizability. These include a lack genetic/familial control confounding limited data examining real world products, full range cannabinoids, motives use specifically in pregnant women. Taken together, reveals need continue improve upon study designs order allow researchers accurately draw conclusions about consequences exposure. Findings such studies would inform policy practices regarding during pregnancy move field toward developing comprehensive teratogenic profile similar what is characterized alcohol tobacco literature.

Language: Английский

Citations

3
The Longitudinal Assessment of Prenatal Cannabis Use on Neonatal Outcomes DOI Creative Commons

Leah habersham,

Yasmin L. Hurd, Yoko Nomura

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: Feb. 5, 2024

Abstract Objective Investigate the association between prenatal cannabis use and neonatal outcomes using longitudinal data from pregnant individuals. Study Design Data was leveraged Stress in Pregnancy study, conducted 2009 2013. Interviews electronic medical records of 894 individuals were analyzed, with 791 identified as cannabis. Cannabis (NICU admission, preterm delivery, low birth weight, fetal death) investigated. Results Among participants 13.1% used cannabis, who generally younger (25.9 vs 27.9 years). Unadjusted analysis indicated a seven-fold increased risk death (OR 7.30) which persisted after adjustments (aOR 6.31). Adjusted models also suggested weight 1.67). Conclusion This study highlights an elevated risks for weight. Funding Support: NIH T32HL160513, NIDA R25DA033211, NIDA R01DA057310, Addiction Institute Mount Sinai internal funds

Language: Английский

Citations

0